世界の前立腺がん診断市場の規模、シェア、トレンド分析レポート
Market Size in USD Billion
CAGR :
% 
USD
4.63 Billion
USD
10.31 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 4.63 Billion |
 Market Size (Forecast Year) |
USD 10.31 Billion |
 CAGR |
% |
| Major Markets Players |
|
世界の前立腺がん診断市場のセグメンテーション、製品タイプ（機器、試薬・消耗品、付属品）、診断タイプ（予備スクリーニング検査、確認検査）、年齢層（成人、小児、老年）、タイプ（前立腺腺がん、小細胞がん、その他）、ステージ（局所性前立腺がん、再発性/進行性前立腺がん、去勢抵抗性前立腺がん）、サンプルタイプ（血液、組織、尿、その他）、エンドユーザー（独立診断研究所、病院、がん研究機関、クリニック、 外来手術センター、 その他）、流通チャネル（直接入札、小売販売） - 2032年までの業界動向と予測
前立腺がん診断市場規模
- 世界の前立腺がん診断市場規模は2024年に46億3000万米ドルと評価され、予測期間中に10.50%のCAGRで成長し、2032年までに103億1000万米ドル に達すると予想されています 。
- 市場の成長は、主に世界中で前立腺がんの罹患率が増加し、早期診断と治療に関する意識が高まったことで、PSA検査、MRI、ゲノム検査などの高度な診断技術の需要が急増したことが要因となっている。
- さらに、医療費の増加と非侵襲性で高精度な診断ツールの開発が相まって、前立腺がん診断は腫瘍学治療における重要な要素として確立されつつあります。これらの要因が重なり、前立腺がん診断ソリューションの導入が加速し、業界の成長を大きく後押ししています。
前立腺がん診断市場分析
- PSA検査、直腸指診（DRE）、MRI、超音波検査、ゲノム検査などのツールを含む前立腺がん診断は、特に50歳以上の男性において、前立腺がんの早期発見と治療においてますます重要な役割を果たしています。早期スクリーニングへの意識の高まりと非侵襲的技術の進歩により、市場は大幅に拡大しています。
- 前立腺がん診断の需要の高まりは、主に世界的な前立腺がん罹患率の増加、がん検査を推進する政府の取り組み、そして精密医療と個別化診断アプローチの採用の増加によって促進されています。
- 北米は、高度な医療インフラ、新しい診断技術の早期導入、有利な償還政策、および高い定期がん検診率を特徴とし、2024年には前立腺がん診断市場において42.8%という最大の収益シェアを占めました。
- アジア太平洋地域は、予測期間中に前立腺がん診断市場において最も急速な成長が見込まれ、年平均成長率（CAGR）は11.2%と予測されています。この成長は、都市化の進展、男性の健康問題への意識の高まり、可処分所得の増加、そして中国、日本、インドなどの国における診断サービスへのアクセス向上に起因しています。
- 試薬・消耗品セグメントは、日常的な検査手順における継続的な使用を背景に、2024年には前立腺がん診断市場において48.6%の市場シェアを占め、市場を牽引しました。バイオマーカー検査や分子検査を含む様々な診断アッセイにおけるこれらの製品の継続的な需要は、臨床現場における前立腺がん診断の効率性と正確性を維持する上で、これらの製品が果たす重要な役割を改めて強調しています。
レポートの範囲と前立腺がん診断市場のセグメンテーション
|
属性 |
前立腺がん診断の主要市場洞察 |
|
対象セグメント |
|
|
対象国 |
北米
ヨーロッパ
アジア太平洋
中東およびアフリカ
南アメリカ
|
|
主要な市場プレーヤー |
|
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、専門家による詳細な分析、価格設定分析、ブランドシェア分析、消費者調査、人口統計分析、サプライチェーン分析、バリューチェーン分析、原材料/消耗品の概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制の枠組みも含まれています。 |
前立腺がん診断市場の動向
「診断精度の向上に向けた先進技術の統合」
- 世界的な前立腺がん診断市場における重要な加速トレンドとして、ゲノムシーケンシング、機械学習アルゴリズム、自動病理プラットフォームといった先進技術の統合が進んでいます。こうしたイノベーションの融合により、診断プロセスの精度、効率性、そしてパーソナライゼーションが向上しています。
- 例えば、Decipher ProstateやProlarisといったプラットフォームは、ゲノム検査を用いて腫瘍の悪性度を評価し、個々の患者のプロファイルに基づいて医師がより適切な治療方針を決定できるよう支援しています。同様に、SelectMDxはmRNAバイオマーカーを評価して前立腺がんの発生確率を予測し、不必要な生検を削減しています。
- 機械学習アルゴリズムは、マルチパラメータMRI（mpMRI）などの画像診断の精度向上にますます活用されています。これらのツールは、臨床的に重要な癌の特定、偽陽性の低減、放射線科医のワークフローの効率化に役立ちます。さらに、自動化されたデジタル病理学システムは、組織学的分析における再現性とスピードを向上させています。
- AIを活用した意思決定支援ツールと電子医療記録（EHR）のシームレスな統合により、腫瘍専門医や泌尿器科医は患者データを一元管理し、リスク層別化のための予測分析を適用することが可能になります。これにより、患者にとってより統一された、エビデンスに基づいた診断プロセスが実現します。
- よりインテリジェントでデータ主導型の診断へのこの傾向は、医師の期待と患者のケアの経路を変革しつつあります。その結果、ミリアド・ジェネティクス、MDxHealth、OPKO Healthなどの企業は、より迅速かつ正確な前立腺がん検出を可能にする分子診断とAIを活用したプラットフォームの開発を継続的に進めています。
- 関係者が早期発見、治療の個別化、そして治療成績の向上を優先するにつれ、バイオマーカー分析、画像技術、臨床意思決定支援を組み合わせた診断ソリューションの需要は、病院、専門クリニック、診断ラボ全体で急速に高まっています。
前立腺がん診断市場の動向
ドライバ
「がん罹患率の上昇と早期発見への意識の高まりによるニーズの高まり」
- 前立腺がんの世界的な負担の増加と早期発見の利点に対する意識の高まりが相まって、高度な前立腺がん診断の需要を刺激する大きな要因となっている。
- 例えば、F. ホフマン・ラ・ロシュ社は2024年4月、前立腺がん患者の早期発見とリスク層別化を強化するため、ゲノムプロファイリングを組み込んだ最新の診断プラットフォームを発表しました。このような戦略的開発は、予測期間中に前立腺がん診断業界の成長を牽引すると予想されます。
- 男性が後期診断や治療合併症のリスクについてより詳しく知るようになるにつれて、正確で非侵襲的かつアクセスしやすい診断ツールの需要が高まっています。
- さらに、前立腺特異抗原（PSA）検査の改善とバイオマーカー、画像技術、ゲノム診断の進歩により、早期スクリーニングはより効率的で信頼できるものとなっている。
- リキッドバイオプシー、マルチパラメータMRI、次世代シーケンシングといった技術は、臨床現場にますます導入され、より個別化された診断と治療の意思決定を支援しています。これらの進化するツールは、不必要な生検の削減、患者体験の向上、そして臨床転帰の向上にも役立っています。
- がんの早期発見を目的とした研究、啓発活動、政府主導の取り組みへの投資の増加も、特に先進国市場において前立腺がん診断の急速な普及に大きく貢献している。
抑制/挑戦
「高度な診断ソリューションへのアクセスが限られており、コストが高い」
- 診断技術の進歩にもかかわらず、地方や発展途上地域における高度な診断サービスへのアクセスは依然として大きな課題です。ゲノム検査、mpMRI、AI駆動型病理学プラットフォームといった最先端ツールの利用は、都市部の三次医療センターや民間機関に限られていることが多いのです。
- さらに、ゲノム検査や分子検査を含むこれらの高度な前立腺がん診断に伴う高額な費用は、適切な保険適用や政府による払い戻しを受けられない患者にとって障壁となる可能性がある。
- 例えば、DecipherやOncotype DX Prostateなどのマルチ遺伝子パネルや高精度腫瘍学ツールは、1回の検査で数百ドルから数千ドルかかる場合があり、価格に敏感な市場では患者を遠ざける可能性がある。
- さらに、複雑な検査結果を解釈するためには、標準化と医師のトレーニングが必要であり、これが一般的な医療現場でのより広範な導入を妨げる可能性がある。
- これらの障害を克服するために、関係者は費用対効果の高いイノベーション、診断インフラの改善に向けた官民連携の強化、そして高度なスクリーニングツールに対する保険や国民健康保険の適用拡大に注力する必要があります。患者と医療提供者への教育の強化も、早期診断と全生存率の向上に重要な役割を果たすでしょう。
前立腺がん診断市場の展望
市場は、製品タイプ、診断タイプ、年齢層、タイプ、段階、サンプルタイプ、エンドユーザー、流通チャネルに基づいてセグメント化されています。
• 製品タイプ別
製品タイプ別に見ると、前立腺がん診断市場は、機器、試薬・消耗品、アクセサリーに分類されます。試薬・消耗品セグメントは、日常的な検査手順における繰り返し使用を背景に、2024年には48.6%の収益シェアで市場を牽引しました。
機器セグメントは、自動診断プラットフォームの需要増加に支えられ、2025年から2032年にかけて7.8%という最速のCAGRを達成すると予想されています。
• 診断の種類別
診断の種類に基づいて、前立腺がん診断市場は予備スクリーニング検査と確認検査に分類されます。PSA検査の普及により、予備スクリーニング検査セグメントは2024年に59.3%と最大の市場シェアを獲得しました。
確認検査セグメントは、バイオマーカー検査とゲノム検査の進歩により、2025年から2032年にかけて8.4%のCAGRで成長すると予測されています。
•年齢別
前立腺がん診断市場は、年齢層別に成人、小児、老年医学に分類されます。2024年には老年医学セグメントが66.7%と最大のシェアを占めました。これは、65歳以上の男性における前立腺がんの有病率の高さに起因しています。
小児における前立腺がんの発生は極めて稀であるため、成人セグメントは2025年から2032年にかけて最も急速なCAGRを示すことが予想されます。
• タイプ別
前立腺がん診断市場は、種類別に前立腺腺がん、小細胞がん、その他に分類されます。前立腺腺がんは2024年には87.4%のシェアを占め、最も一般的な前立腺がんの種類です。
小細胞がんセグメントは、その攻撃的な性質と、より一般的な前立腺がんの種類に比べて予後が悪いことから、希少でありながら臨床的重要性があることを反映して、2025年から2032年にかけて最も速いCAGRを示すことが予想されています。
• ステージ別
前立腺がん診断市場は、ステージに基づいて、局所性前立腺がん、再発／進行性前立腺がん、去勢抵抗性前立腺がんに分類されます。局所性前立腺がんセグメントは、スクリーニングによる早期診断の進展により、2024年には54.9%という最大の市場シェアを獲得しました。
去勢抵抗性前立腺がん（CRPC）セグメントは、2025年から2032年にかけて9.6％という最も高いCAGRを記録すると予測されており、再発性/進行性前立腺がんセグメントは28.3％のシェアを占めています。
• サンプルタイプ別
前立腺がん診断市場は、検体の種類に基づいて、血液、組織、尿、その他に分類されます。血液分野は、PSA検査やその他の血清学的検査の普及により、2024年には46.2%と最大の収益シェアを占めました。
組織セグメントは、正確なステージ分類と個別治療計画のための生検ベースの分子診断への依存度の高まりにより、2025年から2032年にかけて最も速いCAGRを示すことが予想されています。
• エンドユーザーによる
エンドユーザーに基づいて、前立腺がん診断市場は、独立診断研究所、病院、がん研究機関・クリニック、外来手術センター、その他に分類されます。病院は、診断と治療の統合サービスにより、2024年には38.7%のシェアで市場をリードするでしょう。
独立した診断検査室は、専門的な検査の需要の増加、診断結果の迅速化、外来サービスの拡大により、2025年から2032年にかけて9.3%という最も高いCAGRを達成すると予測されています。
•流通チャネル別
流通チャネルに基づいて、前立腺がん診断市場は直接入札と小売販売に区分されます。直接入札セグメントは、2024年には特に機関投資家の間で64.3%のシェアを占め、市場を支配しました。
小売販売セグメントは、便利でアクセスしやすい診断ソリューションに対する消費者の嗜好の高まりにより、2025年から2032年にかけて9.1％という最も高いCAGRを記録すると予想されています。
前立腺がん診断市場の地域分析
- 北米は、前立腺がんの罹患率の高さ、強力な医療インフラ、高度な診断技術の普及により、2024年には前立腺がん診断市場において42.8%という最大の収益シェアを獲得しました。
- この地域は、有利な償還政策、早期スクリーニングプログラム、そして研究開発への強力な投資の恩恵を受けており、これらが相まって市場拡大を支えている。
- 北米で事業を展開する主要企業は、戦略的提携とFDA承認のイノベーションに注力しており、地域市場の成長をさらに促進しています。
米国前立腺がん診断市場の洞察
米国の前立腺がん診断市場は、2024年には北米市場において46.7%と過半数のシェアを占めると予測されています。これは、前立腺がんの罹患率の高さ、認知度の高まり、そしてPSA検査、PCA3、ゲノム検査といった最先端の診断ソリューションの利用可能性に牽引されています。政府の支援策、確立された保険適用範囲、そして個別化医療の導入拡大により、早期かつ正確な診断への需要が加速しています。大手診断企業の強力なプレゼンスと非侵襲性検査ソリューションへの注目度の高まりは、米国市場のパフォーマンスを引き続き向上させています。
欧州前立腺がん診断市場に関する洞察
欧州の前立腺がん診断市場は、厳格なスクリーニング推奨と、正確かつ低侵襲な検査への需要の高まりに支えられ、予測期間を通じて28.5%の着実な成長を記録すると予測されています。医療費の増加、男性人口の高齢化、そして好ましい公衆衛生政策により、この地域全体で早期診断率が上昇しています。分子診断やリキッドバイオプシープラットフォームなどの先進技術は、特に西欧諸国で普及が進んでいます。
英国前立腺がん診断市場の洞察
英国の前立腺がん診断市場は、予測期間中に注目すべきCAGRで成長すると予想されています。これは主に、全国的な啓発活動、NHS（国民保健サービス）が支援するがんスクリーニングの取り組み、そして精密診断の導入拡大に牽引されています。遺伝子検査やバイオマーカー検査を含む個別化がん治療への移行は、診断環境を再構築し、成長機会をもたらしています。強力な臨床試験インフラとそれを支える規制枠組みも、市場の発展に貢献しています。
ドイツにおける前立腺がん診断市場の洞察
ドイツの前立腺がん診断市場は、高水準のケア、診断手順に対する有利な保険適用、そして早期発見への強い重点に支えられ、予測期間中に大幅なCAGRで拡大すると予想されています。診断と電子カルテおよび病院ITシステムの統合により、意思決定と患者管理が向上します。進行中の臨床研究と価値に基づくケアへの重点的な取り組みにより、ドイツにおける高度な前立腺がん診断の役割は引き続き強化されています。
アジア太平洋地域の前立腺がん診断市場に関する洞察
アジア太平洋地域の前立腺がん診断市場は、がんに対する意識の高まり、可処分所得の増加、新興国における医療の近代化を背景に、2025年から2032年にかけて11.2%という最も高い年平均成長率（CAGR）で成長すると予想されています。中国、インド、日本などの国々では、PSA検査および画像診断技術の導入が進み、ゲノムおよび尿検査に基づく診断プラットフォームへの関心も高まっています。政府の保健政策、民間医療の拡大、そしてバイオテクノロジーへの投資の増加が、市場の発展を加速させています。
日本における前立腺がん診断市場の洞察
日本では、男性人口の高齢化と前立腺がん検診率の高さにより、前立腺がん診断市場は着実に拡大しています。画像診断および臨床検査における技術の進歩と、早期発見を重視する文化が相まって、着実な成長を支えています。また、精密診断とAI統合システムも、日本の腫瘍診断研究において注目を集めています。
中国の前立腺がん診断市場の洞察
中国の前立腺がん診断市場は、前立腺がんの罹患率の上昇、医療アクセスの向上、そして診断インフラの急速な拡大により、2024年にはアジア太平洋地域において前立腺がん診断市場への収益貢献度でトップの座を占めました。国の医療改革と、都市部および準都市部におけるがん検診プログラムの急増により、検査件数が増加しています。国内の診断機器メーカーの台頭と戦略的な官民連携も、市場の成長にさらに貢献しています。
前立腺がん診断市場シェア
前立腺がん診断業界は、主に以下のような定評ある企業によって牽引されています。
- F. ホフマン・ラ・ロシュ社（スイス）
- ACON Laboratories, Inc.（米国）
- HUMASIS（韓国）
- テコ・ダイアグノスティクス（米国）
- ホロジック社（米国）
- Accuquik テストキット (米国)
- mdxhealth（ベルギー）
- アボット（米国）
- シーメンス・ヘルシニアーズAG（ドイツ）
- OPKOヘルス社（米国）
- ミリアド・ジェネティクス社（米国）
- DiaSorin SpA（イタリア）
- ベックマン・コールター社（米国）
- ビオメリュー（フランス）
- プロスタタイプ・ジェノミクスAB（スイス）
- 富士レビオ（日本）
- プロテオメディックス（スイス）
- Eurolyser Diagnostica GmbH (オーストリア)
世界の前立腺がん診断市場の最新動向
- 2024年4月、ロシュ・ダイアグノスティックスは、早期前立腺がんの検出において感度と特異度を高めた先進的な前立腺特異抗原（PSA）血液検査を発売しました。この次世代診断ソリューションは、偽陽性率を低減し、早期介入の成果を向上させるように設計されており、世界の前立腺がん診断市場におけるロシュの精密腫瘍診断におけるリーダーシップを強化します。
- 2024年3月、エグザクト・サイエンシズ・コーポレーションは、前立腺がんの診断ポートフォリオを拡大し、疾患の悪性度予測を目的とした新たなゲノム検査プラットフォームを発表しました。この開発は、人工知能とゲノムシーケンシングを活用し、個別化治療計画の支援を行い、プレシジョン・メディシン（精密医療）へのトレンドを後押しします。
- 2024年2月、シーメンス・ヘルステックニアーズは、MRIとAIを活用した分析を統合し、前立腺がんの進行をより正確に検出・モニタリングできる統合画像診断プラットフォームを発表しました。このシステムは現在、欧州と北米の主要病院で導入されており、非侵襲的診断能力の大きな進歩を示しています。
- 2024年1月、バイオテクネ・コーポレーションは、エクソソーム診断部門を通じて、侵襲的処置を必要としない尿を用いた前立腺がん検出のための液体生検検査を導入しました。この検査は米国の泌尿器科クリニックや専門センターで導入が進んでおり、非侵襲的で患者に優しい診断アプローチへの移行を浮き彫りにしています。
- 2023年12月、OPKO Health Inc.は、血液ベースのバイオマーカー検査である4Kscore Testの大規模臨床試験を実施するため、一流の学術医療センターと提携しました。この戦略的提携は、同検査の臨床的有用性と規制承認を世界各国の市場に拡大することを目指しています。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- product type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET end users coverage GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Epidemiology
- COMPARATIVE ANALYSIS WITH PARENT MARKET
- REGULATORY FRAMEWORK: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
- REGULATORY SCENARIO IN THE U.S.
- REGULATORY SCENARIO IN EUROPEAN UNION
- REGULATORY SCENARIO IN JAPAN
- REGULATORY SCENARIO IN CHINA
- market overview
- drivers
- INCREASING PREVALENCE OF PROSTATE CANCER
- INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
- INCREASE IN GERIATRIC POPULATION
- LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
- DISEASE CAUSING PROSTATE CANCER
- RESTRAINTS
- CONTROVERSY RELATED TO PSA TESTING
- HIGH COST OF DIAGNOSTICS PROCEDURE
- LACK OF SKILLED AND CERTIFIED PROFESSIONALS
- OPPORTUNITIES
- RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
- REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
- GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
- RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
- Challenges
- STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
- OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
- INACCURATE DIAGNOSIS RESULTS
- IMPACT OF COVID-19 ON GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
- KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
- CONCLUSION
- global PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
- overview
- reagents & consumables
- instruments
- accessories
- GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
- overview
- preliminary screening tests
- Prostate-Specific Antigen (PSA) Test
- Digital Rectal Exam (DRE) Test
- Confirmatory Tests
- PCA3 Test
- biopsy
- imaging tests
- ULTRASOUND
- MAGNETIC RESONANCE IMAGING (MRI)
- MULTIPARAMETRIC MRI
- MRI FUSION-GUIDED PROSTATE BIOPSY
- CT SCAN
- BONE SCAN
- PET/CT SCAN
- biomarker
- RNA BIOMARKERS
- DNA BIOMARKERS
- PROTEIN BIOMARKERS
- Global prostate cancer diagnostics Market, By type
- overview
- PROSTATIC ADENOCARCINOMA
- small cell carcinoma
- Others
- GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
- overview
- geriatrics
- adult
- Pediatric
- GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
- overview
- LOCALIZED PROSTATE CANCER
- RECURRENT/ADVANCED PROSTATE CANCER
- CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
- GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
- overview
- Blood
- tissue
- urine
- others
- GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
- overview
- Independent Diagnostic Laboratories
- hospitals
- Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- others
- GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
- overview
- direct tender
- retail sales
- GLOBAL Prostate cancer diagnostics maRKET, BY GEOGRAPHY
- OVERVIEW
- NORTH AMERICA
- u.s.
- canada
- mexico
- europe
- GERMANY
- FRANCE
- u.k.
- iTALY
- SPAIN
- RUSSIA
- SWITZERLAND
- NETHERLANDS
- TURKEY
- bELGIUM
- REST OF EUROPE
- Asia - Pacific
- CHINA
- JAPAN
- India
- Australia
- SOUTH KOREA
- SINGAPORE
- THAILAND
- MALAYSIA
- INDONESIA
- Philippines
- REST OF ASIA - PACIFIC
- south AMERICA
- BRAZIL
- ARGENTINa
- rest of south america
- Middle east & africa
- SOUTH AFRICA
- saudi arabia
- uAE
- iSRAEL
- EGYPT
- REST OF MIDDLE EAST & AFRICA
- Global Prostate cancer diagnostics market: COMPANY landscape
- company share analysis: global
- company share analysis: north america
- company share analysis: europe
- company share analysis: Asia-Pacific
- SWOT
- company profile
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHot
- REVENUE ANALYSIS
- company share analysis
- product Portfoli0
- RECENT DEVELOPMENTs
- Abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- siemens HEALTHCARE gmbh
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- OPko HEALTH INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Beckman Coulter, Inc. (A Subsidiary of Danaher)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ACCUQUIK TEST KITS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- acon laboratories inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Biomerieux sa
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Diasorin s.p.a
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLI0
- RECENT DEVELOPMENTS
- Eurolyser Diagnostica GmbH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- FUJIREBIO
- COMPANY SNAPSHOT
- PRODUCT PORTFOLI
- RECENT DEVELOPMENTS
- GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HOLOGIC, INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HUMASIS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- MDXHEALTHCARE
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Metamark genetics, inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLI0
- RECENT DEVELOPMENTS
- Myraid genetics, inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Prostatype Genomics
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- PROTEOMEDIX
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- TECO DIAGNOSTICS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- questionnaire
- related reports
表のリスト
TABLE 1 CATEGORIZATION UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA '88) OF 1988
TABLE 2 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER
TABLE 3 global PROSTATE CANCER DIAGNOSTICS Market, By product type 2019-2028 (USD Million)
TABLE 4 global PROSTATE CANCER DIAGNOSTICS Market, By product type 2019-2028 (UNits)
TABLE 5 global reagents & consumables in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)
TABLE 6 globaL instruments in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)
TABLE 7 globaL accessories in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)
TABLE 8 global PROSTATE CANCER DIAGNOSTICS Market, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)
TABLE 9 global preliminary screening tests in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)
TABLE 10 global Confirmatory Testsin PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)
TABLE 11 Global prostate cancer diagnostics market, By type, 2019-2028 (USD million)
TABLE 12 Global prostatic Adenocarcinomas in prostate cancer diagnostics market, By Type 2019-2028 (USD Million), By Region
TABLE 13 Global small cell carcinoma in prostate cancer diagnostics market, By type, 2019-2028 (USD million)
TABLE 14 Global Others in prostate cancer diagnostics market, By type, 2019-2028 (USD million)
TABLE 15 global PROSTATE CANCER DIAGNOSTICS Market, By age group 2019-2028 (USD Million)
TABLE 16 global geriatrics in PROSTATE CANCER DIAGNOSTICS Market, By region 2019-2028 (USD Million)
TABLE 17 global severe in PROSTATE CANCER DIAGNOSTICS Market, By region, 2019-2028 (USD Million)
TABLE 18 global severe in PROSTATE CANCER DIAGNOSTICS Market, By region, 2019-2028 (USD Million)
TABLE 19 Global Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 20 Global Localized Prostate Cancer in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 21 Global Recurrent/Advanced Prostate Cancer in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 22 Global Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 23 Global Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 24 Global Blood in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 25 Global Tissue in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 26 Global Urine in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 27 Global Others in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 28 Global Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 29 Global Independent Diagnostic Laboratories in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 30 Global Hospitals in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 31 Global Clinics in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 32 Global Ambulatory Surgical Centers in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 33 Global Cancer Research Institutes in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 34 Global Others in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 35 Global Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 36 Global Direct Tender in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 37 Global Hospitals in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)
TABLE 38 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 North America PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)
TABLE 40 North America Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 41 North America Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 42 North America Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 43 North America Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 44 North America Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 45 North America Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 46 North America Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 47 North America Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 48 North America Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 49 North America Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 50 North America Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 51 North America Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 52 North America Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 53 North America Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 54 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 55 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 56 U.S. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 57 U.S. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 58 U.S. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 59 U.S. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 60 U.S. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 61 U.S. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 62 U.S. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 63 U.S. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 64 U.S. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 65 U.S. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 66 U.S. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 67 U.S. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 68 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 69 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 70 CANADA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 71 CANADA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 72 CANADA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 73 CANADA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 74 CANADA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 75 CANADA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 76 CANADA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 77 CANADA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 78 CANADA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 79 CANADA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 80 CANADA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 81 CANADA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 82 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 83 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 84 MEXICO Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 85 MEXICO Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 86 MEXICO Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 87 MEXICO Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 88 MEXICO Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 89 MEXICO Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 90 MEXICO Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 91 MEXICO Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 92 MEXICO Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 93 MEXICO Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 94 MEXICO Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 95 MEXICO Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 96 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)
TABLE 97 EUROPE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 98 EUROPE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 99 EUROPE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 100 EUROPE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 101 EUROPE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 102 EUROPE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 103 EUROPE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 104 EUROPE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 105 EUROPE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 106 EUROPE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 107 EUROPE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 108 EUROPE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 109 EUROPE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 110 EUROPE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 111 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 112 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 113 GERMANY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 114 GERMANY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 115 GERMANY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 116 GERMANY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 117 GERMANY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 118 GERMANY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 119 GERMANY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 120 GERMANY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 121 GERMANY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 122 GERMANY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 123 GERMANY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 124 GERMANY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 125 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 126 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 127 FRANCE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 128 FRANCE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 129 FRANCE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 130 FRANCE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 131 FRANCE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 132 FRANCE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 133 FRANCE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 134 FRANCE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 135 FRANCE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 136 FRANCE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 137 FRANCE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 138 FRANCE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 139 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 140 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 141 U.K. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 142 U.K. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 143 U.K. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 144 U.K. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 145 U.K. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 146 U.K. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 147 U.K. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 148 U.K. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 149 U.K. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 150 U.K. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 151 U.K. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 152 U.K. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 153 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 154 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 155 ITALY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 156 ITALY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 157 ITALY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 158 ITALY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 159 ITALY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 160 ITALY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 161 ITALY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 162 ITALY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 163 ITALY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 164 ITALY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 165 ITALY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 166 ITALY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 167 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 168 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 169 SPAIN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 170 SPAIN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 171 SPAIN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 172 SPAIN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 173 SPAIN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 174 SPAIN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 175 SPAIN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 176 SPAIN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 177 SPAIN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 178 SPAIN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 179 SPAIN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 180 SPAIN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 181 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 182 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 183 RUSSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 184 RUSSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 185 RUSSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 186 RUSSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 187 RUSSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 188 RUSSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 189 RUSSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 190 RUSSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 191 RUSSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 192 RUSSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 193 RUSSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 194 RUSSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 195 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 196 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 197 SWITZERLAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 198 SWITZERLAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 199 SWITZERLAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 200 SWITZERLAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 201 SWITZERLAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 202 SWITZERLAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 203 SWITZERLAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 204 SWITZERLAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 205 SWITZERLAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 206 SWITZERLAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 207 SWITZERLAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 208 SWITZERLAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 209 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 210 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 211 NETHERLANDS Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 212 NETHERLANDS Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 213 NETHERLANDS Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 214 NETHERLANDS Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 215 NETHERLANDS Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 216 NETHERLANDS Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 217 NETHERLANDS Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 218 NETHERLANDS Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 219 NETHERLANDS Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 220 NETHERLANDS Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 221 NETHERLANDS Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 222 NETHERLANDS Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 223 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 224 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 225 TURKEY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 226 TURKEY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 227 TURKEY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 228 TURKEY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 229 TURKEY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 230 TURKEY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 231 TURKEY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 232 TURKEY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 233 TURKEY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 234 TURKEY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 235 TURKEY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 236 TURKEY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 237 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 238 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 239 BELGIUM Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 240 BELGIUM Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 241 BELGIUM Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 242 BELGIUM Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 243 BELGIUM Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 244 BELGIUM Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 245 BELGIUM Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 246 BELGIUM Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 247 BELGIUM Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 248 BELGIUM Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 249 BELGIUM Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 250 BELGIUM Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 251 rest of europe Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 252 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)
TABLE 253 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 254 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 255 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 256 ASIA - PACIFIC Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 257 ASIA - PACIFIC Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 258 ASIA - PACIFIC Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 259 ASIA - PACIFIC Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 260 ASIA - PACIFIC Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 261 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 262 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 263 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 264 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 265 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 266 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 267 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 268 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 269 CHINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 270 CHINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 271 CHINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 272 CHINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 273 CHINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 274 CHINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 275 CHINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 276 CHINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 277 CHINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 278 CHINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 279 CHINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 280 CHINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 281 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 282 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 283 JAPAN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 284 JAPAN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 285 JAPAN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 286 JAPAN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 287 JAPAN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 288 JAPAN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 289 JAPAN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 290 JAPAN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 291 JAPAN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 292 JAPAN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 293 JAPAN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 294 JAPAN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 295 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 296 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 297 INDIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 298 INDIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 299 INDIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 300 INDIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 301 INDIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 302 INDIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 303 INDIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 304 INDIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 305 INDIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 306 INDIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 307 INDIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 308 INDIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 309 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 310 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 311 AUSTRALIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 312 AUSTRALIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 313 AUSTRALIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 314 AUSTRALIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 315 AUSTRALIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 316 AUSTRALIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 317 AUSTRALIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 318 AUSTRALIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 319 AUSTRALIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 320 AUSTRALIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 321 AUSTRALIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 322 AUSTRALIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 323 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 324 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 325 SOUTH KOREA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 326 SOUTH KOREA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 327 SOUTH KOREA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 328 SOUTH KOREA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 329 SOUTH KOREA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 330 SOUTH KOREA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 331 SOUTH KOREA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 332 SOUTH KOREA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 333 SOUTH KOREA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 334 SOUTH KOREA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 335 SOUTH KOREA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 336 SOUTH KOREA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 337 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 338 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 339 SINGAPORE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 340 SINGAPORE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 341 SINGAPORE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 342 SINGAPORE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 343 SINGAPORE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 344 SINGAPORE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 345 SINGAPORE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 346 SINGAPORE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 347 SINGAPORE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 348 SINGAPORE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 349 SINGAPORE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 350 SINGAPORE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 351 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 352 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 353 THAILAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 354 THAILAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 355 THAILAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 356 THAILAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 357 THAILAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 358 THAILAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 359 THAILAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 360 THAILAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 361 THAILAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 362 THAILAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 363 THAILAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 364 THAILAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 365 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 366 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 367 MALAYSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 368 MALAYSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 369 MALAYSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 370 MALAYSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 371 MALAYSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 372 MALAYSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 373 MALAYSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 374 MALAYSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 375 MALAYSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 376 MALAYSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 377 MALAYSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 378 MALAYSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 379 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 380 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 381 INDONESIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 382 INDONESIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 383 INDONESIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 384 INDONESIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 385 INDONESIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 386 INDONESIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 387 INDONESIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 388 INDONESIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 389 INDONESIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 390 INDONESIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 391 INDONESIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 392 INDONESIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 393 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 394 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 395 PHILIPPINES Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 396 PHILIPPINES Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 397 PHILIPPINES Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 398 PHILIPPINES Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 399 PHILIPPINES Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 400 PHILIPPINES Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 401 PHILIPPINES Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 402 PHILIPPINES Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 403 PHILIPPINES Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 404 PHILIPPINES Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 405 PHILIPPINES Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 406 PHILIPPINES Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 407 rest of Asia - Pacific Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 408 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)
TABLE 409 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 410 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 411 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 412 SOUTH AMERICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 413 SOUTH AMERICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 414 SOUTH AMERICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 415 SOUTH AMERICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 416 SOUTH AMERICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 417 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 418 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 419 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 420 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 421 SOUTH AMERICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 422 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 423 BRAZIL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 424 BRAZIL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 425 BRAZIL Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 426 BRAZIL Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 427 BRAZIL Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 428 BRAZIL Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 429 BRAZIL Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 430 BRAZIL Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 431 BRAZIL Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 432 BRAZIL Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 433 BRAZIL Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 434 BRAZIL Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 435 BRAZIL Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 436 BRAZIL Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 437 ARGENTINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 438 ARGENTINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 439 ARGENTINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 440 ARGENTINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 441 ARGENTINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 442 ARGENTINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 443 ARGENTINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 444 ARGENTINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 445 ARGENTINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 446 ARGENTINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 447 ARGENTINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 448 ARGENTINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 449 ARGENTINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 450 ARGENTINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 451 rest of south america Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 452 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)
TABLE 453 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 454 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 455 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 456 MIDDLE EAST & AFRICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 457 MIDDLE EAST & AFRICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 458 MIDDLE EAST & AFRICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 459 MIDDLE EAST & AFRICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 460 MIDDLE EAST & AFRICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 461 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 462 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 463 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 464 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 465 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 466 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 467 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 468 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 469 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 470 SOUTH AFRICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 471 SOUTH AFRICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 472 SOUTH AFRICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 473 SOUTH AFRICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 474 SOUTH AFRICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 475 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 476 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 477 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 478 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 479 SOUTH AFRICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 480 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 481 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 482 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 483 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 484 SAUDI ARABIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 485 SAUDI ARABIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 486 SAUDI ARABIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 487 SAUDI ARABIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 488 SAUDI ARABIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 489 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 490 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 491 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 492 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 493 SAUDI ARABIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 494 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 495 UAE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 496 UAE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 497 UAE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 498 UAE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 499 UAE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 500 UAE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 501 UAE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 502 UAE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 503 UAE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 504 UAE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 505 UAE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 506 UAE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 507 UAE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 508 UAE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 509 ISRAEL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 510 ISRAEL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 511 ISRAEL Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 512 ISRAEL Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 513 ISRAEL Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 514 ISRAEL Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 515 ISRAEL Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 516 ISRAEL Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 517 ISRAEL Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 518 ISRAEL Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 519 ISRAEL Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 520 ISRAEL Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 521 ISRAEL Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 522 ISRAEL Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 523 EGYPT Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 524 EGYPT Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 525 EGYPT Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 526 EGYPT Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 527 EGYPT Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 528 EGYPT Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 529 EGYPT Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 530 EGYPT Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 531 EGYPT Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 532 EGYPT Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 533 EGYPT Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 534 EGYPT Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 535 EGYPT Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 536 EGYPT Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 537 rest of MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
図表一覧
FIGURE 1 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: segmentation
FIGURE 2 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation
FIGURE 3 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: Global VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING
FIGURE 7 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 Global prostate cancer diagnostics market: MARKET end users coverage GRID
FIGURE 10 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 Global prostate cancer diagnostics market: SEGMENTATION
FIGURE 12 NORTH AMERICA is expected to DOMINATE and asia-pacific is growing at the fastest pace in THE global prostate cancer diagnostics market IN the forecast period of 2021 to 2028
FIGURE 13 INCREASING PREVALENCE OF PROSTATE CANCER and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE global Prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 14 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the global prostate cancer diagnostics MARKET in 2021 & 2028
FIGURE 15 asia-PACIFIC is the fastest growing market in global Prostate cancer diagnostics market in the forecast period of 2021 to 2028
FIGURE 16 REGULATORY FRAMEWORK FOR APPROVAL PROCESS IN CHINA
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
FIGURE 18 ESTIMATED INCIDENCE CASES OF PROSTATE CANCER, ALL AGES
FIGURE 19 GERIATRIC POPULATION IN THE EUROPEAN REGION
FIGURE 20 global PROSTATE CANCER DIAGNOSTICS market: BY product type, 2020
FIGURE 21 global PROSTATE CANCER DIAGNOSTICS market: BY product type, 2020-2028 (USD Million)
FIGURE 22 global PROSTATE CANCER DIAGNOSTICS market: BY product type, CAGR (2021-2028)
FIGURE 23 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE
FIGURE 24 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, 2020
FIGURE 25 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE 2020-2028 (USD Million)
FIGURE 26 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, CAGR (2021-2028)
FIGURE 27 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, LIFELINE CURVE
FIGURE 28 Global prostate cancer diagnostics market: By type, 2020
FIGURE 29 Global prostate cancer diagnostics market: By type, 2020-2028 (USD Million)
FIGURE 30 Global prostate cancer diagnostics market: By type, CAGR (2020-2028)
FIGURE 31 Global prostate cancer diagnostics market: By type, LIFELINE CURVE
FIGURE 32 global PROSTATE CANCER DIAGNOSTICS market: BY age group, 2020
FIGURE 33 global PROSTATE CANCER DIAGNOSTICS market: BY age group , 2020-2028 (USD Million)
FIGURE 34 global PROSTATE CANCER DIAGNOSTICS market: BY age group, CAGR (2021-2028)
FIGURE 35 global PROSTATE CANCER DIAGNOSTICS market: BY age group, LIFELINE CURVE
FIGURE 36 global PROSTATE CANCER DIAGNOSTICS market: BY stage, 2020
FIGURE 37 global PROSTATE CANCER DIAGNOSTICS market: BY stage, 2020-2028 (USD Million)
FIGURE 38 global PROSTATE CANCER DIAGNOSTICS market: BY stage, CAGR (2021-2028)
FIGURE 39 global PROSTATE CANCER DIAGNOSTICS market: BY stage, LIFELINE CURVE
FIGURE 40 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, 2020
FIGURE 41 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, 2020-2028 (USD Million)
FIGURE 42 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, CAGR (2021-2028)
FIGURE 43 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, LIFELINE CURVE
FIGURE 44 global PROSTATE CANCER DIAGNOSTICS market: BY end users, 2020
FIGURE 45 global PROSTATE CANCER DIAGNOSTICS market: BY end users, 2020-2028 (USD Million)
FIGURE 46 global PROSTATE CANCER DIAGNOSTICS market: BY end users, CAGR (2021-2028)
FIGURE 47 global PROSTATE CANCER DIAGNOSTICS market: BY end users, LIFELINE CURVE
FIGURE 48 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, 2020
FIGURE 49 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, 2020-2028 (USD Million)
FIGURE 50 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, CAGR (2021-2028)
FIGURE 51 global PROSTATE CANCER DIAGNOSTICS market: BY distribution, LIFELINE CURVE
FIGURE 52 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)
FIGURE 53 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)
FIGURE 54 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 55 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 56 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY pRODUCT type (2020-2028)
FIGURE 57 North America Prostate cancer diagnostics market: SNAPSHOT (2020)
FIGURE 58 North America Prostate Cancer Diagnostics Market: BY COUNTRY (2020)
FIGURE 59 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 60 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 61 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)
FIGURE 62 EUROPE Prostate cancer diagnostics market: SNAPSHOT (2020)
FIGURE 63 EUROPE Prostate Cancer Diagnostics Market: BY COUNTRY (2020)
FIGURE 64 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 65 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 66 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)
FIGURE 67 ASIA - PACIFIC Prostate cancer diagnostics market: SNAPSHOT (2020)
FIGURE 68 ASIA - PACIFIC Prostate Cancer Diagnostics Market: BY COUNTRY (2020)
FIGURE 69 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 70 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 71 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)
FIGURE 72 SOUTH AMERICA Prostate cancer diagnostics market: SNAPSHOT (2020)
FIGURE 73 SOUTH AMERICA Prostate Cancer Diagnostics Market: BY COUNTRY (2020)
FIGURE 74 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 75 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 76 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)
FIGURE 77 MIDDLE EAST & AFRICA Prostate cancer diagnostics market: SNAPSHOT (2020)
FIGURE 78 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market: BY COUNTRY (2020)
FIGURE 79 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 80 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 81 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)
FIGURE 82 Global Prostate cancer diagnostics market: company share 2020 (%)
FIGURE 83 north america Prostate cancer diagnostics market: company share 2020 (%)
FIGURE 84 europe Prostate cancer diagnostics market: company share 2020 (%)
FIGURE 85 Asia-Pacific Prostate cancer diagnostics market: company share 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
